[ Back to EurekAlert! ]

Contact: Ellen Goldbaum
goldbaum@buffalo.edu
716-645-4605
University at Buffalo

Andrew Talal, University at Buffalo

Caption: Talal led the study, which is the first to track in real-time, how the drug telaprevir inhibits viral replication in the liver.

Credit: Douglas Levere, University at Buffalo

Usage Restrictions: None

Related news release: How long should HCV treatment last? Study suggests answers are complex


[ Back to EurekAlert! ]